pd 169316 has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiao, C | 1 |
| Zhong, L | 1 |
| Shan, Z | 1 |
| Xu, T | 1 |
| Gan, L | 1 |
| Song, H | 1 |
| Yang, R | 1 |
| Li, L | 1 |
| Liu, B | 1 |
1 other study available for pd 169316 and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK.
Topics: Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neopl | 2016 |